drugset / Trial / NCT02965404

A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children

NCT02965404 ↗

Phase 1 Completed 270 enrolled Sinovac (Dalian) Vaccine Technology Co., Ltd.
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to evaluate the safety of a live attenuated varicella vaccine in healthy adults, adolescents, and children.

Timeline

Start
2016-04
Primary completion
2016-05
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Investigational live attenuated varicella vaccine Vaccine 0.5 ml Intramuscular
Comparator control live attenuated varicella vaccine Vaccine 0.5 ml Intramuscular

Indications